NEW MARKERS FOR CARDIOVASCULAR RISK: FROM STUDIES TO CLINICAL GUIDELINES

<p>New markers for cardiovascular disease (CVD) risk are the subject of an intensive discussion in the scientific literature. The biomarkers (new<br />lipid parameters, inflammatory markers) and signs of subclinical atherosclerosis are candidates to be included in models to assess the cu...

Full description

Bibliographic Details
Main Authors: D. A. Anichkov, N. A. Shostak
Format: Article
Language:Russian
Published: ABV-press 2014-11-01
Series:Klinicist
Subjects:
Online Access:http://klinitsist.abvpress.ru/index.php/Klin/article/view/140
_version_ 1797969671898529792
author D. A. Anichkov
N. A. Shostak
author_facet D. A. Anichkov
N. A. Shostak
author_sort D. A. Anichkov
collection DOAJ
description <p>New markers for cardiovascular disease (CVD) risk are the subject of an intensive discussion in the scientific literature. The biomarkers (new<br />lipid parameters, inflammatory markers) and signs of subclinical atherosclerosis are candidates to be included in models to assess the cumulative risk of CVD. The paper considers the basic studies dealing with new markers of CVD risk and their place in current clinical recommendations.</p>
first_indexed 2024-04-11T03:04:45Z
format Article
id doaj.art-2eda3ac81bd742f4a94518d810a3478b
institution Directory Open Access Journal
issn 1818-8338
language Russian
last_indexed 2024-04-11T03:04:45Z
publishDate 2014-11-01
publisher ABV-press
record_format Article
series Klinicist
spelling doaj.art-2eda3ac81bd742f4a94518d810a3478b2023-01-02T13:15:41ZrusABV-pressKlinicist1818-83382014-11-018148155NEW MARKERS FOR CARDIOVASCULAR RISK: FROM STUDIES TO CLINICAL GUIDELINESD. A. Anichkov0N. A. Shostak1Acad. A.I. Nesterov Department of Faculty Therapy, N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia, MoscowAcad. A.I. Nesterov Department of Faculty Therapy, N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia, Moscow<p>New markers for cardiovascular disease (CVD) risk are the subject of an intensive discussion in the scientific literature. The biomarkers (new<br />lipid parameters, inflammatory markers) and signs of subclinical atherosclerosis are candidates to be included in models to assess the cumulative risk of CVD. The paper considers the basic studies dealing with new markers of CVD risk and their place in current clinical recommendations.</p>http://klinitsist.abvpress.ru/index.php/Klin/article/view/140cardiovascular diseasespreventionrisk rating scalesbiomarkersclinical guidelines
spellingShingle D. A. Anichkov
N. A. Shostak
NEW MARKERS FOR CARDIOVASCULAR RISK: FROM STUDIES TO CLINICAL GUIDELINES
Klinicist
cardiovascular diseases
prevention
risk rating scales
biomarkers
clinical guidelines
title NEW MARKERS FOR CARDIOVASCULAR RISK: FROM STUDIES TO CLINICAL GUIDELINES
title_full NEW MARKERS FOR CARDIOVASCULAR RISK: FROM STUDIES TO CLINICAL GUIDELINES
title_fullStr NEW MARKERS FOR CARDIOVASCULAR RISK: FROM STUDIES TO CLINICAL GUIDELINES
title_full_unstemmed NEW MARKERS FOR CARDIOVASCULAR RISK: FROM STUDIES TO CLINICAL GUIDELINES
title_short NEW MARKERS FOR CARDIOVASCULAR RISK: FROM STUDIES TO CLINICAL GUIDELINES
title_sort new markers for cardiovascular risk from studies to clinical guidelines
topic cardiovascular diseases
prevention
risk rating scales
biomarkers
clinical guidelines
url http://klinitsist.abvpress.ru/index.php/Klin/article/view/140
work_keys_str_mv AT daanichkov newmarkersforcardiovascularriskfromstudiestoclinicalguidelines
AT nashostak newmarkersforcardiovascularriskfromstudiestoclinicalguidelines